CIK: 1184228 - Address: C/O Ngm Biopharmaceuticals, Inc., 333 Oyster Point Boulevard, South San Francisco, CA 94080
15 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret1170-0-2-3-5-6-3
S%wins57718671718674

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

11/8/18 16:31
11/8/18
MRKMerck & Co., Inc.NJHealthDrugPharmaceutical PreparationsPerlmutter Roger MNJOExe V-P,M.d10,14044.980225142D
11/8/18 16:31
11/8/18
MRKMerck & Co., Inc.NJHealthDrugPharmaceutical PreparationsPerlmutter Roger MNJOExe V-P,S.d-16,96875.270-225-61142D
5/9/16 16:21
5/6/16
MRKMerck & Co., Inc.NJHealthDrugPharmaceutical PreparationsPerlmutter Roger MNJOExe V-P,M.d00.00334418968D2-8-291-5-5-31051910
2/6/12 17:35
2/2/12
AMGNAmgen IncDEHealthBioPrdBiological Products, (No DiagPerlmutter Roger MCAOEVP,ReseM.d4,39658.61337568186D22263627102020-3-312028
2/6/12 17:35
2/2/12
AMGNAmgen IncDEHealthBioPrdBiological Products, (No DiagPerlmutter Roger MCAOEVP,ReseS.d-5,23769.8333-75-29186D22263627102020-3-312028
6/2/09 19:22
6/2/09
AMGNAmgen IncDEHealthBioPrdBiological Products, (No DiagPerlmutter Roger MCAOExe VP,RM.d3,26138.363385132149D-1114-105105-1120418120
6/2/09 19:22
6/2/09
AMGNAmgen IncDEHealthBioPrdBiological Products, (No DiagPerlmutter Roger MCAOExe VP,RS.d-4,34151.0733-85-36149D-1114-105105-1120418120
11/21/05 12:37
11/17/05
AMGNAmgen IncDEHealthBioPrdBiological Products, (No DiagPerlmutter Roger MCAOExe VP,RS-2,88182.3033-35-4248D3839345910421-2-6-10-20-12
11/21/05 12:36
11/17/05
AMGNAmgen IncDEHealthBioPrdBiological Products, (No DiagPerlmutter Roger MCAOExe VP,RM.d5,86958.693310083D3839345910421-2-6-10-20-12
11/21/05 12:36
11/17/05
AMGNAmgen IncDEHealthBioPrdBiological Products, (No DiagPerlmutter Roger MCAOExe VP,RS.d-5,35282.3533-65-4483D3839345910421-2-6-10-20-12
7/28/05 17:01
7/27/05
AMGNAmgen IncDEHealthBioPrdBiological Products, (No DiagPerlmutter Roger MCAOExe VP,RS.m-60981.2033-8-1348D164328403621150-24-2-6-11-14
7/28/05 17:01
7/27/05
AMGNAmgen IncDEHealthBioPrdBiological Products, (No DiagPerlmutter Roger MCAOExe VP,RM.d1,53438.36334025356D164328403621150-24-2-6-11-14
7/28/05 17:01
7/27/05
AMGNAmgen IncDEHealthBioPrdBiological Products, (No DiagPerlmutter Roger MCAOExe VP,RS.d-2,63281.0033-33-3756D164328403621150-24-2-6-11-14
8/4/03 09:47
7/31/03
AMGNAmgen IncDEHealthBioPrdBiological Products, (No DiagPerlmutter Roger MCAOExe VP,RM95938.3633255868D18573485-3-2-20-2-1-10-3-17
8/4/03 09:47
7/31/03
AMGNAmgen IncDEHealthBioPrdBiological Products, (No DiagPerlmutter Roger MCAOExe VP,RS-1,77070.8033-25-2768D18573485-3-2-20-2-1-10-3-17

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact